Background: As a third-generation antiseizure medication (ASM). lacosamide (LCM) is recommended worldwide for patients with epilepsy. We aimed to provide more conclusive evidence for the safety and tolerability of LCM in patients with epilepsy. Methods: A systematic search was performed on MEDLINE. https://www.lightemupsequences.com/